麻花视频 University Clinical Associate Professor of Community Care Dr. Melissa Mattison, has been selected as the sub awardee of a $50,000 grant under the University of Rhode Island (URI) for naloxone education. The grant aims to educate healthcare professionals and the community about naloxone, a life-saving medication that can rapidly reverse opioid overdose.
Naloxone is an FDA-approved medication that works as an opioid antagonist, binding to opioid receptors and reversing and blocking the effects of other opioids such as heroin, morphine, and oxycodone. When administered to someone showing signs of opioid overdose, naloxone provides temporary treatment and its effects do not last long. As such, it is crucial to obtain medical intervention as soon as possible after administering or receiving naloxone.
Naloxone can be given by intranasal spray (into the nose), intramuscular (into the muscle), subcutaneous (under the skin), or intravenous (into the vein) injection. Healthcare practitioners must assess the need to prescribe naloxone for patients receiving medication-assisted treatment (MAT) or considered at risk for opioid overdose.
The grant will focus on promoting on-line modules and resources to community partners and residents and other healthcare professionals, including students, about naloxone administration, its importance, and the proper steps to take in case of an opioid overdose. With the rising prevalence of opioid use, such education will be crucial to save lives and prevent further harm to the community. URI is partnering with institutions across New England to bring education to rural counties.
"Receiving this grant is an honor, and I look forward to utilizing it to raise awareness about naloxone and its life-saving benefits," said Dr. Mattison. "By educating community members and healthcare professionals about naloxone administration, we can take significant steps towards preventing opioid overdose and improving public health."
is an Associate Clinical Professor of Pharmacy Practice and Assistant Dean of Experiential Affairs with over 25 years of experience in the community providing quality care to patients. She is committed to advocating for public health and implementing evidence-based interventions to improve patient lives and outcomes.
